AIHTA - Publications - Search - Nivolumab (Opdivo®) as monotherapy for the treatment of unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma (OESCC)

Grössmann, N. (2020): Nivolumab (Opdivo®) as monotherapy for the treatment of unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma (OESCC). Oncology Fact Sheet Nr. 26.

[thumbnail of Oncology Fact Sheet Nr.26.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
79kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WI Digestive system > WI 250 Oesophagus
Language:English
Series Name:Oncology Fact Sheet Nr. 26
Deposited on:18 Nov 2020 11:48
Last Modified:18 Nov 2020 11:48

Repository Staff Only: item control page